Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical benefit of cancer drugs

Guidelines including grading of novel drugs with ESMO MCBS


09 Oct 2016


Clinical benefit of cancer drugs


Andrés Cervantes


A. Cervantes

Author affiliations

  • S. Hematologia Y Oncologia, Hospital Clinico Universitario, 46010 - Valencia/ES


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings